NewswireToday - /newswire/ -
Belfast, United Kingdom, 2014/07/10 - PathXL announced a global partnership with Indica Labs to resell HALO™, their next generation image analysis platform - IndicaLab.com / PathXL.com. NYSE: PHG, AEX: PHIA
HALO was designed by Indica Labs to be the fastest, most scalable, user-friendly image analysis software for digital pathology applications. By reselling HALO suite, PathXL will further extend its ability to serve the broadest needs of the market.
The platform features Indica’s large portfolio of morphometric and colorimetric analysis tools for neuroscience, metabolism, oncology, and toxicological pathology. HALO provides cell-by-cell results, making it ideally suited for quantification of cell-based immunohistochemistry, immunofluorescence and in situ hybridization (ISH) assays.
Analysis can be performed across large studies of whole slide images or on single field-of-view images, and HALO’s modular design supports both affordable, small-scale, desktop environments and high-throughput, multi-node, networked environments.
"Image analysis is a key requirement for today’s advanced Digital Pathology systems," says Des Speed, CEO of PathXL. "We see great synergy between Indica Labs’ extensive portfolio of image analysis algorithms and PathXL’s focus on top quality products for the digital pathology lab. The HALO platform together with the Indica algorithms will further deepen PathXL’s commitment to excellence in tumor analysis and in the delivery of next generation solutions for the Pathologist."
Steven Hashagen, Indica CEO added,"We are excited about this new partnership with PathXL which will help to drive the continued adoption of our HALO image analysis platform. PathXL has a successful history of delivering advanced solutions for digital pathology and a deep understanding of customer needs in this market. PathXL’s scanner agnostic approach fits well with our own focus on providing advanced image analysis solutions to every part of the market."
About PathXL Ltd
PathXL (pathxl.com) is a global pioneer in the use of web-based solutions for digital pathology and provides innovative software for use in research, clinical and education applications worldwide. The company focuses specifically on the oncology sector aiming to provide expertise and excellence in tumor analysis. PathXL’s award winning product, TissueMark®, assists the Pathologist with an automated analysis of tumor boundary and % tumor content across a range of tumor types, greatly reducing errors due to the natural variability in human assessment. For more information on HALO from PathXL, please visit our website or contact our sales team.
About Indica Labs, Inc.
Indica Labs (indicalab.com) provides software for quantitative evaluation of pathology images. Indica’s HALO image analysis platform provides a unique combination of precision, performance, scalability, and usability. Indica’s broad range of industry leading tissue-specific image analysis algorithms can be used in a variety of truly integrated digital pathology environments, allowing pharmaceutical, healthcare, and research organizations worldwide to apply high-throughput image quantification in areas such as neuroscience, metabolism, oncology, toxicological pathology, and more. For more information, please contact info[.]indicalab.com